相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment-Experienced Subjects: 48-Week Results of the VICTOR-E1 Phase 2 Trial
Jamal Suleiman et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients
Aylin Yilmaz et al.
AIDS (2009)
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
Christina M. Marraa et al.
AIDS (2009)
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
Pablo Labarga et al.
AIDS (2009)
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients
Priscilla Y. Hsue et al.
AIDS (2009)
Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients
Gerd Faetkenheuer et al.
AIDS (2009)
Continuous antiretroviral therapy decreases bone mineral density
Birgit Grund et al.
AIDS (2009)
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
Benoit Marin et al.
AIDS (2009)
High Frequency of Vitamin D Deficiency in Ambulatory HIV-Positive Patients
M. Rodriguez et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study
Julia Bohlius et al.
ANTIVIRAL THERAPY (2009)
Coronary Aging in HIV-Infected Patients
Giovanni Guaraldi et al.
CLINICAL INFECTIOUS DISEASES (2009)
Better Adherence with Once-Daily Antiretroviral Regimens: A Meta-Analysis
Jean-Jacques Parienti et al.
CLINICAL INFECTIOUS DISEASES (2009)
Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment
Colleen F. Kelley et al.
CLINICAL INFECTIOUS DISEASES (2009)
Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
Anna Maria Geretti et al.
CLINICAL INFECTIOUS DISEASES (2009)
High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial
Y. Yazdanpanah et al.
CLINICAL INFECTIOUS DISEASES (2009)
Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART
B. O. Taiwo et al.
HIV MEDICINE (2009)
Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome
N. F. Oenen et al.
HIV MEDICINE (2009)
Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression
Roger J. Bedimo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression
Weiwei Cao et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
Todd T. Brown et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation
Sonia Molina-Pinelo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Microbial translocation is associated with residual viral replication in HAART-treated HIV plus subjects with <50 copies/ml HIV-1 RNA
Silvia Baroncelli et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Cumulative HIV Viremia during Highly Active Antiretroviral Therapy Is a Strong Predictor of AIDS-Related Lymphoma
Alexander Zoufaly et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4+ T Cells
Martyn A. French et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection
Wei Jiang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4+ T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy
Timothy P. Brennan et al.
JOURNAL OF VIROLOGY (2009)
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Jeffrey L. Lennox et al.
LANCET (2009)
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study
Marguerite Guiguet et al.
LANCET ONCOLOGY (2009)
Interleukin-2 Therapy in Patients with HIV Infection
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Mari M. Kitahata et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa
Andrew D. Redd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
Jerry Polesel et al.
AIDS (2008)
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
A. d'Arminio Monforte et al.
AIDS (2008)
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy
Giulia Marchetti et al.
AIDS (2008)
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
Robert C. Kaplan et al.
AIDS (2008)
CD4+count and risk of non-AIDS diseases following initial treatment for HIV infection
Jason V. Baker et al.
AIDS (2008)
Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system
Scott Letendre et al.
ARCHIVES OF NEUROLOGY (2008)
Poor initial CD4+recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases
Jason V. Baker et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Changes in the risk of death after HIV seroconversion compared with mortality in the general population
Krishnan Bhaskaran et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection
Lin Shen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults
Jeffrey M. Jacobson et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection
Raphael J. Landovitz et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy -: The ACTG (AIDS Clinical Trials Group) study 5152s
Francesca J. Torriani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study:: a multi-cohort collaboration
Caroline A. Sabin et al.
LANCET (2008)
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Lin Shen et al.
NATURE MEDICINE (2008)
Class-sparing regimens for initial treatment of HIV-1 infection
Sharon A. Riddler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty
Loic Desquilbet et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2007)
Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count <200 cells/μl when viral replication is suppressed
Gianni E. D'Egidio et al.
AIDS (2007)
The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS
Nancy A. Hessol et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3
Bryan Lau et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART
Marco Marziali et al.
AIDS (2006)
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection
Benigno Rodriguez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: A meta-analysis
MF Miller et al.
CLINICAL INFECTIOUS DISEASES (2005)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/μL in HIV type 1-infected individuals receiving potent antiretroviral therapy
GR Kaufmann et al.
CLINICAL INFECTIOUS DISEASES (2005)
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads
O Benveniste et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Tolerability and safety of HIV protease inhibitors in adults
PE Sax et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Immune activation set point during early FHV infection predicts subsequent CD4+ T-cell changes independent of viral load
SG Deeks et al.
BLOOD (2004)
Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration
C Eggers et al.
AIDS (2003)
Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy
J Kulkosky et al.
CLINICAL INFECTIOUS DISEASES (2002)
Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans
S Mouly et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults
JA Bartlett et al.
AIDS (2001)
Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction
JH Stein et al.
CIRCULATION (2001)
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence from the EuroSIDA study
JP Viard et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
分享论文
